ALC Stock Forecast & Price Target

Alcon is a global leader in ophthalmic surgical equipment, consumables, and implantables, as well as contact lenses and ocular health products. The company has shown a consistent history of delivering top-line growth and innovative products, and is expected to continue to do so with a 6-8% revenue growth and double-digit EPS growth. With a strong brand portfolio and a growing installed base of eye surgical equipment, Alcon is well-positioned for future growth and is a solid investment opportunity.

Alcon is a leading visioncare company, but its outlook is negative due to its declining revenue growth, uncertain market conditions, and potential tariff impacts. While the company has a robust product pipeline and a strong presence in the US contact lens market, these factors may not be enough to sustain its growth in the face of market challenges. Moreover, its planned capital allocation for M&A and stock buybacks may not have the desired impact on its financial performance, given its lack of revenue growth.